Skip to main content
ACR Convergence 2024 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Emerging Investigator Awardee
Emerging Investigator Awardee
Back

Scientific Session

Epidemiology, health policy and outcomes

Session: Envisioning a Steroid-Free Future for the Treatment of Rheumatic Diseases

Recognize the Evolving Role of Steroids in Management of ANCA-Vasculitis

Sunday, November 17, 2024
10:30 AM – 10:50 AM Eastern Time
Location: Room 146AB
CME In Person On Demand

    Speaker(s)

  • JS

    John Stone, MD,MPH

    Professor of Medicine; The Edward Fox Chair in Medicine
    Massachusetts General Hospital , Harvard Medical School
    Concord, MA, United States

    Disclosure(s): Abvie: Consultant (Ongoing); Amgen: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Argenx: Consultant (Ongoing); Aztrazeneca: Consultant (Terminated, December 31, 2022); Bristol Myers Squibb: Consultant (Ongoing), Grant/Research Support (Ongoing); Celgene: Consultant (Terminated, December 31, 2022); Chemocentryx: Consultant (Terminated, December 31, 2022); Chugai: Consultant (Terminated, December 31, 2022); GSK: Consultant (Terminated, December 31, 2022); Horizon Therapeutics: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing); InflaRx: Consultant (Terminated, December 31, 2022); IQVIA: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Kyverna: Consultant (Terminated, December 31, 2022); Mirabio: Consultant (Terminated, December 31, 2022); NIH: Grant/Research Support (Ongoing); Novartis: Consultant (Ongoing); PPD: Consultant (Ongoing); Prometheus: Consultant (Ongoing); Q32: Consultant (Ongoing); Regeneron: Consultant (Terminated, December 31, 2022); Roche-Genentech: Consultant (Ongoing); Roivant: Consultant (Terminated, December 31, 2022); Sanofi: Consultant (Ongoing), Grant/Research Support (Ongoing); Spruce Biosciences: Consultant (Terminated, December 31, 2022); Star Therapeutics: Consultant (Ongoing); Steritas: Chair, Scientific Advisory Board (no fiduciary responsibilities) (Ongoing); ZenasBio: Consultant (Ongoing)